Literature DB >> 21349095

Immunity to salmonellosis.

Gordon Dougan1, Victoria John, Sophie Palmer, Pietro Mastroeni.   

Abstract

Salmonella enterica is a genetically broad species harboring isolates that display considerable antigenic heterogeneity and significant differences in virulence potential. Salmonella generally exhibit an invasive potential and they can survive for extended periods within cells of the immune system. They cause acute or chronic infections that can be local (e.g. gastroenteritis) or systemic (e.g. typhoid). In vivo Salmonella infections are complex with multiple arms of the immune system being engaged. Both humoral and cellular responses can be detected and characterized, but full protective immunity is not always induced, even following natural infection. The murine model has proven to be a fertile ground for exploring immune mechanisms and observations in the mouse have often, although not always, correlated with those in other infectable species, including humans. Host genetic studies have identified a number of mammalian genes that are central to controlling infection, operating both in innate and acquired immune pathways. Vaccines, both oral and parenteral, are available or under development, and these have been used with some success to explore immunity in both model systems and clinically in humans.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 21349095     DOI: 10.1111/j.1600-065X.2010.00999.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  86 in total

1.  Coming of AGE: facile generation of attenuated vaccine strains through heterologous gene expression.

Authors:  Carlos C Goller; Patrick C Seed
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

2.  Vaccination with a single CD4 T cell peptide epitope from a Salmonella type III-secreted effector protein provides protection against lethal infection.

Authors:  Jonathan R Kurtz; Hailey E Petersen; Daniel R Frederick; Lisa A Morici; James B McLachlan
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Cross-reactive multifunctional CD4+ T cell responses against Salmonella enterica serovars Typhi, Paratyphi A and Paratyphi B in humans following immunization with live oral typhoid vaccine Ty21a.

Authors:  Rezwanul Wahid; Stephanie Fresnay; Myron M Levine; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2016-09-12       Impact factor: 3.969

4.  Unexpected Role of CD8 T Cells in Accelerated Clearance of Salmonella enterica Serovar Typhimurium from H-2 Congenic mice.

Authors:  Jasmine C Labuda; Claire E Depew; Oanh H Pham; Joseph M Benoun; Nora A Ramirez; Stephen J McSorley
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 5.  Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence.

Authors:  John S Gunn; Joanna M Marshall; Stephen Baker; Sabina Dongol; Richelle C Charles; Edward T Ryan
Journal:  Trends Microbiol       Date:  2014-07-22       Impact factor: 17.079

6.  Coinfection with an intestinal helminth impairs host innate immunity against Salmonella enterica serovar Typhimurium and exacerbates intestinal inflammation in mice.

Authors:  Libo Su; Chien-wen Su; Yujuan Qi; Guilian Yang; Mei Zhang; Bobby J Cherayil; Xichen Zhang; Hai Ning Shi
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

Review 7.  Gas-filled microbubbles: Novel mucosal antigen-delivery system for induction of anti-pathogen's immune responses in the gut.

Authors:  Blaise Corthésy; Gilles Bioley
Journal:  Gut Microbes       Date:  2017-05-25

8.  Optimal protection against Salmonella infection requires noncirculating memory.

Authors:  Joseph M Benoun; Newton G Peres; Nancy Wang; Oanh H Pham; Victoria L Rudisill; Zachary N Fogassy; Paul G Whitney; Daniel Fernandez-Ruiz; Thomas Gebhardt; Quynh-Mai Pham; Lynn Puddington; Sammy Bedoui; Richard A Strugnell; Stephen J McSorley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

9.  L-asparaginase II produced by Salmonella typhimurium inhibits T cell responses and mediates virulence.

Authors:  Amy L Kullas; Michael McClelland; Hee-Jeong Yang; Jason W Tam; AnnMarie Torres; Steffen Porwollik; Patricio Mena; Joseph B McPhee; Lydia Bogomolnaya; Helene Andrews-Polymenis; Adrianus W M van der Velden
Journal:  Cell Host Microbe       Date:  2012-12-13       Impact factor: 21.023

10.  Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation-induced T cell metabolic reprogramming.

Authors:  AnnMarie Torres; Joanna D Luke; Amy L Kullas; Kanishk Kapilashrami; Yair Botbol; Antonius Koller; Peter J Tonge; Emily I Chen; Fernando Macian; Adrianus W M van der Velden
Journal:  J Leukoc Biol       Date:  2015-10-23       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.